blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0904366

EP0904366 - APO-2LI AND APO-3 APOPTOSIS POLYPEPTIDES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.05.2009
Database last updated on 16.09.2024
Most recent event   Tooltip01.05.2009Application deemed to be withdrawnpublished on 03.06.2009  [2009/23]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [1999/13]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / ASHKENAZI, Avi, J.
1456 Tarrytown Street
San Mateo, CA 94402 / US
[1999/13]
Representative(s)Kiddle, Simon John, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2005/50]Kiddle, Simon John, et al
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP / GB
Former [1999/13]O'Brien, Caroline Jane
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date97917736.731.03.1997
[1999/13]
WO1997US05230
Priority number, dateUS1996062532801.04.1996         Original published format: US 625328
US1996071080223.09.1996         Original published format: US 710802
[1999/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9737020
Date:09.10.1997
Language:EN
[1997/43]
Type: A1 Application with search report 
No.:EP0904366
Date:31.03.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.1997 takes the place of the publication of the European patent application.
[1999/13]
Search report(s)International search report - published on:EP09.10.1997
ClassificationIPC:C12N15/12, C07K14/715, C07K14/47, C12N5/10, C07K16/18, C07K16/46, A61K38/17, A01K67/027
[1999/13]
CPC:
C07K14/47 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
C07K14/70578 (EP,US); A01K2217/05 (EP,US); A61K38/00 (EP,US);
C07K2319/00 (EP,US); C07K2319/30 (EP,US); C07K2319/40 (EP,US);
Y10S435/81 (EP,US); Y10S435/975 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/13]
TitleGerman:APO-2LI UND APO-3 APOPTOSIS POLYPEPTIDE[2007/17]
English:APO-2LI AND APO-3 APOPTOSIS POLYPEPTIDES[1999/13]
French:POLYPEPTIDES DE L'APOPTOSE APO-2LI ET APO-3[2007/17]
Former [1999/13]APO-2LI AND APO-3 APOPTOSIS POLYPEPTIDEN
Former [1999/13]POLYPEPTIDES DE L'APOPTOSE APO-2L1 ET APO-3
Entry into regional phase21.10.1998National basic fee paid 
21.10.1998Designation fee(s) paid 
21.10.1998Examination fee paid 
Examination procedure22.08.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.10.1998Examination requested  [1999/13]
23.05.2001Despatch of a communication from the examining division (Time limit: M08)
21.05.2002Reply to a communication from the examining division
27.02.2003Despatch of a communication from the examining division (Time limit: M06)
04.09.2003Reply to a communication from the examining division
11.02.2004Despatch of a communication from the examining division (Time limit: M05)
23.06.2004Reply to a communication from the examining division
16.08.2004Despatch of communication that the application is refused, reason: substantive examination {1}
24.05.2006Despatch of a communication from the examining division (Time limit: M06)
05.03.2007Reply to a communication from the examining division
11.04.2007Communication of intention to grant the patent
22.08.2007Application deemed to be withdrawn, date of legal effect  [2009/23]
16.01.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/23]
Appeal following examination18.10.2004Appeal received No.  T0070/05
23.12.2004Statement of grounds filed
07.02.2006Result of appeal procedure: continuation of examination procedure
07.02.2006Date of oral proceedings
10.02.2006Minutes of oral proceedings despatched
Divisional application(s)EP04014636.7  / EP1500702
Request for further processing for:05.03.2007Request for further processing filed
05.03.2007Full payment received (date of receipt of payment)
Request granted
11.04.2007Decision despatched
21.05.2002Request for further processing filed
21.05.2002Full payment received (date of receipt of payment)
Request granted
07.06.2002Decision despatched
Fees paidRenewal fee
11.03.1999Renewal fee patent year 03
13.03.2000Renewal fee patent year 04
16.03.2001Renewal fee patent year 05
13.03.2002Renewal fee patent year 06
11.03.2003Renewal fee patent year 07
15.03.2004Renewal fee patent year 08
14.03.2005Renewal fee patent year 09
09.03.2006Renewal fee patent year 10
14.03.2007Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.03.200812   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0510691  (OSAKA BIOSCIENCE INST [JP]) [A] 1-45 * the whole document *;
 [PX]  - KITSON J ET AL, "A death-domain-containing receptor that mediates apoptosis.", NATURE, NOV 28 1996, 384 (6607) P372-5, ENGLAND, XP002036560 [PX] 19-27,32-39 * the whole document *

DOI:   http://dx.doi.org/10.1038/384372a0
 [PX]  - CHINNAIYAN AM ET AL, "Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95.", SCIENCE, NOV 8 1996, 274 (5289) P990-2, UNITED STATES, XP000676685 [PX] 19-27,32-39 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.274.5289.990
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.